Brief: Akero Says If Deal Terminated, Co To Pay $165 Million Termination Fee To Novo Nordisk
Oct 9 (Reuters) - Akero Therapeutics Inc AKRO.O: AKERO THERAPEUTICS INC - IF DEAL TERMINATED UNDER SOME CIRCUMSTANCES, CO TO PAY $165 MILLION TERMINATION FEE TO NOVO NORDISK- SEC FILING AKERO THERAPEUTICS: NOVO NORDISK TO PAY CO REVERSE TERMINATION FEE OF $185 MILLION IF DEAL TERMINATED UNDER SOME CIRCUMSTANCES Further company coverage: AKRO.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Akero Therapeutics
See all newsBrief: Novo Nordisk Completes Acquisition Of Akero Therapeutics
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Germany's Cartel Office Says It Approved Acquisition Of Akero Therapeutics By Novo Nordisk
Brief: Akero Therapeutics Stockholders Approve Acquisition By Novo Nordisk